ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/09/22 | 1,200 | 1,200 | 1,102 | 1,132 | -68 | -5.7% | 1,686,300 |
2017/09/21 | 1,130 | 1,200 | 1,114 | 1,200 | +84 | +7.5% | 1,341,400 |
2017/09/20 | 1,108 | 1,135 | 1,090 | 1,116 | -5 | -0.4% | 519,900 |
2017/09/19 | 1,125 | 1,149 | 1,096 | 1,121 | +35 | +3.2% | 738,500 |
2017/09/15 | 1,032 | 1,093 | 1,027 | 1,086 | +27 | +2.5% | 735,800 |
2017/09/14 | 1,122 | 1,130 | 1,032 | 1,059 | -71 | -6.3% | 1,200,000 |
2017/09/13 | 1,115 | 1,179 | 1,115 | 1,130 | +2 | +0.2% | 1,330,600 |
2017/09/12 | 1,070 | 1,130 | 1,052 | 1,128 | +84 | +8% | 1,372,700 |
2017/09/11 | 1,075 | 1,090 | 1,034 | 1,044 | +29 | +2.9% | 1,014,400 |
2017/09/08 | 1,004 | 1,026 | 994 | 1,015 | +11 | +1.1% | 1,304,700 |
2017/09/07 | 1,060 | 1,116 | 999 | 1,004 | -46 | -4.4% | 2,069,800 |
2017/09/06 | 996 | 1,101 | 967 | 1,050 | +10 | +1% | 3,285,800 |
2017/09/05 | 1,261 | 1,284 | 998 | 1,040 | -230 | -18.1% | 5,947,000 |
2017/09/04 | 1,415 | 1,435 | 1,263 | 1,270 | -170 | -11.8% | 3,783,400 |
2017/09/01 | 1,326 | 1,440 | 1,326 | 1,440 | +107 | +8% | 1,919,000 |
2017/08/31 | 1,316 | 1,345 | 1,292 | 1,333 | +27 | +2.1% | 779,300 |
2017/08/30 | 1,319 | 1,350 | 1,256 | 1,306 | -3 | -0.2% | 1,665,200 |
2017/08/29 | 1,289 | 1,317 | 1,256 | 1,309 | -10 | -0.8% | 970,800 |
2017/08/28 | 1,336 | 1,412 | 1,307 | 1,319 | +1 | +0.1% | 1,856,900 |
2017/08/25 | 1,299 | 1,326 | 1,291 | 1,318 | +18 | +1.4% | 642,000 |
2017/08/24 | 1,350 | 1,358 | 1,293 | 1,300 | -36 | -2.7% | 1,445,100 |
2017/08/23 | 1,272 | 1,336 | 1,250 | 1,336 | +76 | +6% | 1,326,400 |
2017/08/22 | 1,290 | 1,336 | 1,236 | 1,260 | -29 | -2.2% | 1,431,300 |
2017/08/21 | 1,252 | 1,329 | 1,216 | 1,289 | +49 | +4% | 1,578,700 |
2017/08/18 | 1,250 | 1,307 | 1,232 | 1,240 | -54 | -4.2% | 1,361,000 |
2017/08/17 | 1,308 | 1,339 | 1,275 | 1,294 | +1 | +0.1% | 1,372,500 |
2017/08/16 | 1,340 | 1,367 | 1,271 | 1,293 | -32 | -2.4% | 2,026,600 |
2017/08/15 | 1,226 | 1,398 | 1,226 | 1,325 | +110 | +9.1% | 3,120,900 |
2017/08/14 | 1,141 | 1,233 | 1,093 | 1,215 | +14 | +1.2% | 2,364,500 |
2017/08/10 | 1,357 | 1,357 | 1,185 | 1,201 | -66 | -5.2% | 2,802,000 |
2017/08/09 | 1,300 | 1,372 | 1,195 | 1,267 | +7 | +0.6% | 4,434,900 |
2017/08/08 | 1,313 | 1,329 | 1,222 | 1,260 | -97 | -7.1% | 2,288,100 |
2017/08/07 | 1,411 | 1,457 | 1,340 | 1,357 | -44 | -3.1% | 1,171,500 |
2017/08/04 | 1,389 | 1,467 | 1,355 | 1,401 | -18 | -1.3% | 1,494,900 |
2017/08/03 | 1,546 | 1,565 | 1,381 | 1,419 | -131 | -8.5% | 2,158,200 |
2017/08/02 | 1,521 | 1,628 | 1,512 | 1,550 | -16 | -1% | 1,494,800 |
2017/08/01 | 1,651 | 1,651 | 1,537 | 1,566 | -101 | -6.1% | 1,569,300 |
2017/07/31 | 1,638 | 1,685 | 1,570 | 1,667 | +2 | +0.1% | 1,632,600 |
2017/07/28 | 1,781 | 1,819 | 1,606 | 1,665 | -100 | -5.7% | 2,334,600 |
2017/07/27 | 1,837 | 1,850 | 1,751 | 1,765 | -90 | -4.9% | 1,775,600 |
2017/07/26 | 1,755 | 1,908 | 1,736 | 1,855 | +110 | +6.3% | 3,521,000 |
2017/07/25 | 1,681 | 1,755 | 1,681 | 1,745 | +29 | +1.7% | 970,400 |
2017/07/24 | 1,699 | 1,780 | 1,650 | 1,716 | +41 | +2.4% | 1,807,300 |
2017/07/21 | 1,676 | 1,712 | 1,644 | 1,675 | -1 | -0.1% | 807,200 |
2017/07/20 | 1,651 | 1,720 | 1,651 | 1,676 | +36 | +2.2% | 1,638,900 |
2017/07/19 | 1,652 | 1,659 | 1,580 | 1,640 | -24 | -1.4% | 1,638,500 |
2017/07/18 | 1,693 | 1,786 | 1,660 | 1,664 | +4 | +0.2% | 4,491,500 |
2017/07/14 | 1,541 | 1,730 | 1,515 | 1,660 | +130 | +8.5% | 5,664,300 |
2017/07/13 | 1,529 | 1,571 | 1,501 | 1,530 | -49 | -3.1% | 1,676,200 |
2017/07/12 | 1,609 | 1,666 | 1,504 | 1,579 | +2 | +0.1% | 6,092,100 |
1751~
1800
件表示中 / 3268件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 46,200円 | +138.6% | - | 0.00% | 42.35倍 | 1.78倍 |
|
ファイザー旧国内研究所が前身。導出した発売済み消化器薬等収益柱に成長、低分子創薬に強い |
ソレイジア | 5,000円 | +102.6% | - | 0.00% | - | 5.54倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
ペルセウス | 72,300円 | 0.0% | - | 0.00% | - | 6.06倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体(ADC)開発 |
モダリス | 14,100円 | - | - | 0.00% | - | 8.93倍 |
|
遺伝子治療薬の創薬ベンチャー、切断しない独自のゲノム編集技術に強み。研究開発中心は米国 |
仁 丹 | 211,400円 | +2.4% | +10.4% | 2.60% | 12.36倍 | 0.69倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
市場注目の銘柄
チャート関連のコラム